These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 35944210)

  • 1. Probable role of exosomes in the extension of fibrotic alterations from affected to normal cells in systemic sclerosis.
    Jimenez SA; Piera-Velazquez S
    Rheumatology (Oxford); 2023 Mar; 62(3):999-1008. PubMed ID: 35944210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosomes isolated from serum of systemic sclerosis patients display alterations in their content of profibrotic and antifibrotic microRNA and induce a profibrotic phenotype in cultured normal dermal fibroblasts.
    Wermuth PJ; Piera-Velazquez S; Jimenez SA
    Clin Exp Rheumatol; 2017; 35 Suppl 106(4):21-30. PubMed ID: 28094758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial to mesenchymal transition (EndoMT) in the pathogenesis of Systemic Sclerosis-associated pulmonary fibrosis and pulmonary arterial hypertension. Myth or reality?
    Jimenez SA; Piera-Velazquez S
    Matrix Biol; 2016 Apr; 51():26-36. PubMed ID: 26807760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosomes in Systemic Sclerosis: Messengers Between Immune, Vascular and Fibrotic Components?
    Colletti M; Galardi A; De Santis M; Guidelli GM; Di Giannatale A; Di Luigi L; Antinozzi C
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31487964
    [No Abstract]   [Full Text] [Related]  

  • 5. Antifibrotic effects and mechanisms of mesenchymal stem cell-derived exosomes in a systemic sclerosis mouse model: Possible contribution of miR-196b-5p.
    Baral H; Uchiyama A; Yokoyama Y; Sekiguchi A; Yamazaki S; Amalia SN; Inoue Y; Ogino S; Torii R; Hosoi M; Matsuzaki T; Motegi SI
    J Dermatol Sci; 2021 Oct; 104(1):39-47. PubMed ID: 34479773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human dermal fibroblast-derived exosomes induce macrophage activation in systemic sclerosis.
    Bhandari R; Yang H; Kosarek NN; Smith AE; Garlick JA; Hinchcliff M; Whitfield ML; Pioli PA
    Rheumatology (Oxford); 2023 Feb; 62(SI):SI114-SI124. PubMed ID: 35946522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered expression of CD63 and exosomes in scleroderma dermal fibroblasts.
    Nakamura K; Jinnin M; Harada M; Kudo H; Nakayama W; Inoue K; Ogata A; Kajihara I; Fukushima S; Ihn H
    J Dermatol Sci; 2016 Oct; 84(1):30-39. PubMed ID: 27443953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Pro-fibrotic Myofibroblasts in Systemic Sclerosis: From Origin to Therapeutic Targeting.
    Romano E; Rosa I; Fioretto BS; Matucci-Cerinic M; Manetti M
    Curr Mol Med; 2022; 22(3):209-239. PubMed ID: 33823766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune complexes containing scleroderma-specific autoantibodies induce a profibrotic and proinflammatory phenotype in skin fibroblasts.
    Raschi E; Chighizola CB; Cesana L; Privitera D; Ingegnoli F; Mastaglio C; Meroni PL; Borghi MO
    Arthritis Res Ther; 2018 Aug; 20(1):187. PubMed ID: 30157947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bosentan reverses the pro-fibrotic phenotype of systemic sclerosis dermal fibroblasts via increasing DNA binding ability of transcription factor Fli1.
    Akamata K; Asano Y; Aozasa N; Noda S; Taniguchi T; Takahashi T; Ichimura Y; Toyama T; Sato S
    Arthritis Res Ther; 2014 Apr; 16(2):R86. PubMed ID: 24708674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic reprogramming of glycolysis and glutamine metabolism are key events in myofibroblast transition in systemic sclerosis pathogenesis.
    Henderson J; Duffy L; Stratton R; Ford D; O'Reilly S
    J Cell Mol Med; 2020 Dec; 24(23):14026-14038. PubMed ID: 33140521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Fibrotic Diseases: Current Challenges in Fibrosis Research.
    Rosenbloom J; Macarak E; Piera-Velazquez S; Jimenez SA
    Methods Mol Biol; 2017; 1627():1-23. PubMed ID: 28836191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidative stress-induced senescence mediates inflammatory and fibrotic phenotypes in fibroblasts from systemic sclerosis patients.
    Kizilay Mancini O; Acevedo M; Fazez N; Cuillerier A; Fernandez Ruiz A; Huynh DN; Burelle Y; Ferbeyre G; Baron M; Servant MJ
    Rheumatology (Oxford); 2022 Mar; 61(3):1265-1275. PubMed ID: 34115840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-cell analysis reveals fibroblast heterogeneity and myofibroblasts in systemic sclerosis-associated interstitial lung disease.
    Valenzi E; Bulik M; Tabib T; Morse C; Sembrat J; Trejo Bittar H; Rojas M; Lafyatis R
    Ann Rheum Dis; 2019 Oct; 78(10):1379-1387. PubMed ID: 31405848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel multi-network approach reveals tissue-specific cellular modulators of fibrosis in systemic sclerosis.
    Taroni JN; Greene CS; Martyanov V; Wood TA; Christmann RB; Farber HW; Lafyatis RA; Denton CP; Hinchcliff ME; Pioli PA; Mahoney JM; Whitfield ML
    Genome Med; 2017 Mar; 9(1):27. PubMed ID: 28330499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolving insights into the cellular and molecular pathogenesis of fibrosis in systemic sclerosis.
    Korman B
    Transl Res; 2019 Jul; 209():77-89. PubMed ID: 30876809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular SPARC cooperates with TGF-β signalling to induce pro-fibrotic activation of systemic sclerosis patient dermal fibroblasts.
    Carvalheiro T; Malvar Fernández B; Ottria A; Giovannone B; Marut W; Reedquist KA; Garcia S; Radstake TR
    Rheumatology (Oxford); 2020 Sep; 59(9):2258-2263. PubMed ID: 31840182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of the transforming growth factor β-inducible gene HIC-5 in systemic sclerosis skin and fibroblasts: a novel antifibrotic therapeutic target.
    Piera-Velazquez S; Fertala J; Huaman-Vargas G; Louneva N; Jiménez SA
    Rheumatology (Oxford); 2020 Oct; 59(10):3092-3098. PubMed ID: 32442272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bosentan and macitentan prevent the endothelial-to-mesenchymal transition (EndoMT) in systemic sclerosis: in vitro study.
    Corallo C; Cutolo M; Kahaleh B; Pecetti G; Montella A; Chirico C; Soldano S; Nuti R; Giordano N
    Arthritis Res Ther; 2016 Oct; 18(1):228. PubMed ID: 27716320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced SPAG17 Expression in Systemic Sclerosis Triggers Myofibroblast Transition and Drives Fibrosis.
    Sapao P; Roberson EDO; Shi B; Assassi S; Skaug B; Lee F; Naba A; Perez White BE; Córdova-Fletes C; Tsou PS; Sawalha AH; Gudjonsson JE; Ma F; Verma P; Bhattacharyya D; Carns M; Strauss JF; Sicard D; Tschumperlin DJ; Champer MI; Campagnola PJ; Teves ME; Varga J
    J Invest Dermatol; 2023 Feb; 143(2):284-293. PubMed ID: 36116512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.